Matthew Pierce

Scan.com is transforming diagnostic imaging, a $500B+ global market, by rebuilding its outdated infrastructure from the ground up. Having built the UK’s largest marketplace for self-pay MRI scans, we’re now scaling at breakneck speed to become the world’s leading medical imaging platform. Our mission is clear: make medical imaging radically accessible—because early, efficient diagnostics save lives. Inefficiency shouldn’t cost lives. By integrating fragmented imaging providers, payers, and technology into a seamless, modern ecosystem, we’re creating an effortless, patient-first experience that improves healthcare outcomes globally. Backed by top-tier VCs across the US & Europe, we’ve raised $50M+ to date and are just getting started. Join us as we redefine the future of medical imaging.

Welcome to VenueScanner, our mission is to connect people in the world’s best spaces! Discover and book the best space for your team offsite, meeting, workshop, party, wedding or photo shoot. We save you valuable time in finding and booking the ideal venue. That way you can use your time creating the perfect event instead. www.venuescanner.com

Cydar Medical is a global cloud-based software company that provides an integrated solution for planning, navigation and review of surgical procedures powered by Artificial Intelligence.   As leaders in our field, our mission is to transform the way information is provided to clinicians at every stage of the patient pathway to inform better clinical decision-making.   We believe that our clinicians should have the world’s experience at their fingertips, and we will help achieve this vision by using the latest cutting-edge AI technology to enable them to make faster, easier, and safer decisions.  Our first product, Cydar EV Maps, is in use in leading centers across the globe. The system generates a patient-specific 3D map of relevant soft tissue that updates real-time to optimise procedure planning and intra-operative navigation as well as allowing assessment of outcomes. The AI will learn from all procedures globally to provide predictive analytics to assist our clinicians in the OR.

People deserve more from their money. More visibility, more control, and more freedom. Since 2015, Revolut has been on a mission to deliver just that. Our powerhouse of products help our 70+ million customers get more from their money every day. As we continue our lightning-fast growth,‌ 2 things are essential to our success: our people and our culture. In recognition of our outstanding employee experience, weve been certified as a Great Place to Work™. So far, we have 10,000+ people working around the world, from our offices and remotely, to help us achieve our mission. And were looking for more brilliant people. People who love building great products, redefining success, and turning the complexity of a chaotic world into the simplicity of a beautiful solution.

At fundamental XR, we use immersive technology—like VR, AR, MR, Haptics, Web and App—to transform how surgical teams train and adopt complex procedures.

Adaptix (www.adaptix.com) is transforming planar X-ray – the diagnostic imaging modality most widely used in healthcare worldwide. We are producing a Flat Panel X-ray Source (‘FPS’), a ‘Distributed Array Monoblock’ that generates X-ray from a multitude of emitters in a two-dimensional form factor. The best analogy is of the journey in televisions from old-fashioned vacuum tubes to Flat Panel displays. The reason this is important is that it completes the ‘digitization’ of X-ray systems. Partnering a Flat Panel Source with existing dynamic Flat Panel Detectors, in conjunction with low-cost computing power and sophisticated algorithms, allows truly-portable low-cost low-dose tomosynthesis - in essence, 3D imaging at the bedside. Current X-ray equipment gives a choice between fixed high-cost 3D systems or lower-cost (but still expensive) 2D that can be moveable (typically at >200kg). Our FPS allows a transformation, where systems move from a single high-flux tube to multiple low-flux distribute emitters, to allow more information (including 3D) from less dose. Adaptix will allow System Integrators to offer truly portable 3D systems at a price point that meets that of existing 2D systems. Multi-award winning Adaptix is fortunate to be supported by the Royal Academy of Engineering, through its "SME Leaders"​ programme; by the European Space Agency, through its Business Incubation Centre at Harwell; by the Duke of York, through "Pitch@Palace"​; and, by the London Stock Exchange, through the "Elite"​ business support and capital raising programme.

Our proprietary technology includes a novel method to make nanoMIPs which circumvents the drawbacks of traditional MIP manufacturing methods. NanoMIPS are, as the name suggests, nanostructured polymer particles typically containing a single binding site for their target. They can also be fused to solid substrates, such as sensor surfaces, if required. The robust nature of MIPs and nanoMIPs make them ideal reagents for a wide range of applications including point-of-care diagnostics and in field based testing. As they are synthetic polymers, MIPs can withstand harsh chemical environments such as extremes of pH, seawater, or high concentrations of organic solvents. In addition, MIPs have a very long shelf life at room temperature which makes them ideal when the cold chain cannot be guaranteed. MIPs have successfully been created and deployed against all major target classes including peptides, proteins and other macromolecular structures, as well as smaller chemical entities such as drugs, their metabolites and commonly used biochemical species such as enzyme cofactors. Using our proprietary nanoMIP design and development process, MIP Diagnostics can provide a proven nanoMIP typically within 4-6 weeks of receiving the target.

Tozaro is developing a novel suite of reagents to help transform the development and manufacture of viral vectors in cell and gene therapy. Operating at the intersection of chemistry and biology, Tozaro’s smart polymers are evolving existing analytical and purification processes to realize a future where advanced therapies are accessible to all.

LIfT Biosciences is a biotech bringing to market a first-in-class alpha neutrophil cell therapy that overcomes the limitations of current therapies in solid tumours by destroying tumours both directly and indirectly. LIfT’s Immunomodulatory Alpha Neutrophils (IMANs) turn the tumour microenvironment against the tumour as they recruit the rest of the immune system to destroy the tumour to give a durable response and lasting immunity. The patented breakthrough N-LIfT platform is produced from a patented process using exceptional stem cells (iPSC or HSC), a proprietary enhancement media and genetic engineering (e.g. CARs). The resulting CAR-IMAN cells give cancer patients potentially hundreds of times the cancer killing ability they naturally possess. The company is working with a range of pharmaceutical license partners to develop a portfolio of CAR-IMAN cell therapies to deliver complete remission across all solid tumours before the decade is out. LIfT BioSciences was founded by Alex Blyth following the death of his mother to pancreatic cancer. See www.liftbiosciences.com. We are now speaking to syndicate partners for our forthcoming Series A POC Clinical Trial, and co-development partners for commercialisation.

Congenica is a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale. We drive Precision Medicine and help reduce the burden on healthcare systems by delivering automated analysis, diagnosis and treatment solutions to healthcare providers and patients worldwide. Congenica’s Platform is the only product of its kind that has received the CE Mark under the In Vitro Diagnostics Directive for both rare diseases and somatic and inherited cancer, and is uniquely placed to drive ubiquitous use of complex data in routine clinical care. Our products and services are consolidated on one single scalable, automated analysis and diagnostic platform that encompasses inherited disease, somatic cancer, pharma insights and pathogen surveillance. Congenica was founded based on pioneering work at the Wellcome Trust Sanger Institute and the UK NHS. We are the exclusive clinical decision support partner for the NHS Genomic Medicine Service and have a global footprint supporting leading international laboratories, academic medical centres, hospitals and biopharmaceutical companies.

GENinCode specializes in risk assessment and prediction of cardiovascular disease , thrombosis and familial hypercholesterolemia . Cardiovascular disease (CVD) is a broad disease classification including coronary artery disease such as angina and myocardial infarction often referred to as heart attack. CVD also includes stroke, heart failure, hypertension and other vascular heart diseases and is the leading cause of death and disability worldwide accounting for 1 in every 4 deaths in the United States. GENinCode provides advanced genomic technology, products and recommendations fully validated by our scientific and clinical team. Our goal is to provide doctors and health care practitioners with advanced health information that combines both traditional clinical measures with a patient’s genetic information to provide a comprehensive risk assessment and clinical recommendation to help decision-making. Our technology helps select the optimal treatment pathway and informs and educates patients to become more aware of their cardiovascular risk helping patient adherence and empowerment to better manage their health. GENinCode technology and advanced genomic products provide information that helps patients and healthcare practitioners to assess and predict the onset of cardiovascular disease, thrombosis, and the diagnosis of Familial Hypercholesterolemia. Our online reporting system SITAB® helps inform doctors of their patients’ health risk enabling patient behavioral and lifestyle changes alongside delivering the most effective therapies and treatment pathways.

Engine B is a digital technology company specialising in AI and data analytics for the professional services industry. Working alongside the audit, legal and tax sectors, our mission is to open up company to company interactions with next-generation technology and innovation. With our Audit Common Data Model and Knowledge Graphs, we are transforming the way that audit services are delivered and helping to create a level playing field, where any size of audit firm can compete. We work with key industry partners, such as Microsoft, audit firms, the ICAEW and educational institutions to vastly improve the quality of professional services practices and to empower organisations with the technology to make contextual, intelligent decisions. Contact hello@engineb.com for more information on our Audit Common Data Model and Knowledge Graphs.

M3TRIQ automates the design of ligands that match your target signaling pathways

Scan.com is transforming diagnostic imaging, a $500B+ global market, by rebuilding its outdated infrastructure from the ground up. Having built the UK’s largest marketplace for self-pay MRI scans, we’re now scaling at breakneck speed to become the world’s leading medical imaging platform. Our mission is clear: make medical imaging radically accessible—because early, efficient diagnostics save lives. Inefficiency shouldn’t cost lives. By integrating fragmented imaging providers, payers, and technology into a seamless, modern ecosystem, we’re creating an effortless, patient-first experience that improves healthcare outcomes globally. Backed by top-tier VCs across the US & Europe, we’ve raised $50M+ to date and are just getting started. Join us as we redefine the future of medical imaging.

Welcome to VenueScanner, our mission is to connect people in the world’s best spaces! Discover and book the best space for your team offsite, meeting, workshop, party, wedding or photo shoot. We save you valuable time in finding and booking the ideal venue. That way you can use your time creating the perfect event instead. www.venuescanner.com

Cydar Medical is a global cloud-based software company that provides an integrated solution for planning, navigation and review of surgical procedures powered by Artificial Intelligence.   As leaders in our field, our mission is to transform the way information is provided to clinicians at every stage of the patient pathway to inform better clinical decision-making.   We believe that our clinicians should have the world’s experience at their fingertips, and we will help achieve this vision by using the latest cutting-edge AI technology to enable them to make faster, easier, and safer decisions.  Our first product, Cydar EV Maps, is in use in leading centers across the globe. The system generates a patient-specific 3D map of relevant soft tissue that updates real-time to optimise procedure planning and intra-operative navigation as well as allowing assessment of outcomes. The AI will learn from all procedures globally to provide predictive analytics to assist our clinicians in the OR.

People deserve more from their money. More visibility, more control, and more freedom. Since 2015, Revolut has been on a mission to deliver just that. Our powerhouse of products help our 70+ million customers get more from their money every day. As we continue our lightning-fast growth,‌ 2 things are essential to our success: our people and our culture. In recognition of our outstanding employee experience, weve been certified as a Great Place to Work™. So far, we have 10,000+ people working around the world, from our offices and remotely, to help us achieve our mission. And were looking for more brilliant people. People who love building great products, redefining success, and turning the complexity of a chaotic world into the simplicity of a beautiful solution.